• There are no suggestions because the search field is empty.

Patient Enrolment and Retention in Clinical Trials: How to Improve Recruitment and Keep Patients Engaged

Author Avatar
Laura Drikite, Clinical Project Manager at QbD Group
Clinical
Medical Devices
Calander_icon
person-image
Laura Drikite, Clinical Project Manager at QbD Group

Learn key strategies to boost patient enrolment and retention in clinical trials—from clear criteria and site engagement to patient-centric trial design.

Improving Patient Recruitment & Retention in Clinical Trials | QbD Group
7:54

In clinical research, the success of a trial heavily depends on two key factors: recruiting enough eligible participants and retaining them throughout the study. While this may sound simple in theory, in practice, it’s one of the most resource-intensive and challenging aspects of trial execution.

In this blog post, we explore:

  • Why patient enrolment and retention are critical to study success
  • Practical strategies to improve recruitment
  • How to enhance retention through patient-focused trial design
  • And how QbD Group can support you throughout the process

Let’s take a closer look at each of these areas.

 

Why Are Patient Enrolment and Retention So Important?

The number of patients needed in a trial is defined by statistical power calculations that take into account the trial’s objectives, the expected effect size, and the confidence level required. Under-recruitment or high dropout rates can compromise statistical validity, introduce bias, and ultimately prevent regulatory approval of a new treatment.

In addition to scientific concerns, poor recruitment or high attrition can cause delays and inflate budgets—particularly if additional sites need to be opened or recruitment periods extended. Given the costs associated with infrastructure, staff, and patient reimbursements, failing to meet targets often translates to wasted resources and missed opportunities.

 

Strategies to Improve Patient Recruitment

The following strategies could be considered to achieve the required patient recruitment targets in clinical research studies:

 

1. Define Clear Eligibility Criteria

Patient recruitment can be streamlined by defining clear eligibility criteria. This ensures that only the most suitable patients are considered for the trial.

This way, site teams can focus on screening patients who are more likely to meet the trial requirements, reducing the time spent screening and, in some cases, even recruiting unsuitable candidates.

Moreover, screening patients based on well-defined eligibility criteria reduces variability, leading to improved study validity and more reliable results.

2. Engage and Train Site Investigators

Motivated and well-informed site teams are critical for achieving recruitment targets. Effective strategies include:

  • Comprehensive protocol training on the trial protocol and eligibility criteria to avoid protocol deviations and streamline screening
  • Investigator meetings to provide important progress updates and allow knowledge sharing between sites. Investigator meetings are a good tool to remind sites about the trial and re-motivate site teams to actively participate in the trial.
  • Practical materials:
    • Pocket cards with eligibility criteria
    • Sheets where the screening process is clearly presented – these can be very useful to be placed at nursing stations, physicians’ desk or site’s clinical trials centre/office
    • Posters in staff rooms – these can be used to remind site staff about checking whether their patients are eligible for the trial
    • Trial branded pens or other office supplies
  • Scientific or professional incentives, including co-authorship and acknowledgements, to encourage active participation

3. Enhance Patient Engagement

Patients make the final decision to participate, so their needs and understanding must be prioritized:

Provide clear and accessible information

  • Use lay-friendly materials to explain the purpose and procedures of the trial.
  • Involve patient representatives in the development of patient-facing documents to ensure clarity and avoid confusion.
  • Go beyond simply handing out information sheets—take time to verbally explain the trial and confirm patient understanding.
  • In case of a language barrier, use a professional interpreter to avoid excluding certain patient groups.
  • Share post-trial updates in an accessible format (e.g., via the study physician, poster, or leaflet in the waiting room) to keep participants informed and valued.
  • Thank patients and caregivers with a postcard or similar token at the end of study participation to foster a sense of belonging and appreciation.

Raise awareness through onsite materials

  • Place posters or leaflets with key trial information in patient waiting rooms or hospital wards.
  • This allows patients to learn about ongoing studies and initiate a conversation with site staff if interested.

Adapt consent procedures to the target population

  • Choose methods that suit the patient group—for example, avoid e-consent for elderly populations who may lack access to digital devices.
  • Provide age-appropriate information sheets and assent forms when involving paediatric patients.

Consider appropriate financial incentives

  • Offer compensation—such as gift vouchers or direct transfers—to acknowledge the time and effort patients invest by participating in the trial.

 

It’s crucial that patients never feel pressured to join a trial. Sufficient time, space for questions, and external consultation should always be part of the decision-making process.

Remember: all patient-facing materials must be reviewed by an Independent Ethics Committee.

 

 

Strategies to Improve Patient Retention

 

1. Involve Patient Representatives Early

Involving patient groups during the trial design phase can help create more patient-friendly protocols, improving retention.

2. Make Follow-Up Easier

Address logistical barriers by:

  • Understanding Standard of Care patient hospital paths and mimic the flow in the protocol schedule of assessments
  • Offering home visits, where appropriate
  • Scheduling appointments during evenings or weekends
  • Sending paper questionnaires with return envelopes and reminders
  • Providing alternatives, such as phone-based follow-ups

3. Reimburse Travel and Related Costs

Covering transportation or other expenses helps reduce the burden of participation, especially for patients traveling specifically for trial visits.

4. Maintain Active Communication

Proactive reminders by email, SMS, or phone calls can reduce missed visits. Offering flexible ways to complete tasks—like phone questionnaires—can also boost participation.

5. Keep Patients Informed

Trial websites, newsletters, or dedicated portals help keep patients informed, engaged and show that their contribution is valued.

6. Collect and Use Patient Feedback

Feedback gathered through trusted healthcare providers can help improve future trials and increase retention.

How QbD Group Can Support Patient Recruitment and Retention

At QbD Clinical, we combine regulatory expertise with operational excellence to help sponsors run successful trials—on time and within budget.

Our multidisciplinary team of regulatory specialists, safety managers, medical writers, clinical project managers, and CRAs work closely together to support your recruitment and retention strategy. Here’s how we can help:

 

  • Writing recruitment plans
  • Developing patient-facing materials (ICFs, leaflets, etc.)
  • Monitoring recruitment and follow-up progress
  • Training site teams
  • Organizing investigator meetings

Need help improving recruitment and retention in your trial?

QbD Clinical supports you from start to finish—ensuring your study stays compliant, efficient, and patient-centric.

Let's talk.

 

Stay ahead in life sciences

Keeping up with the fast-paced life sciences industry doesn’t have to be overwhelming.

Our newsletter delivers the latest insights, industry updates, and expert content directly to your inbox, helping you stay informed and make smarter decisions.

Circles-banner-short

Discover more expert content

preview_image
Case study

Fast-Tracked Site Qualification for Clinical Trial Submission

QbD Group helped a biotech company complete 5 site qualification visits in just 3 weeks enabling a timely and compliant clinical trial submission.
preview_image
Webinar

Evidence Throughout the Lifecycle: Integrating Clinical Needs into Design & Documentation

Discover how to integrate clinical needs into medical device software design to meet MDR requirements. Watch our webinar on demand.
preview_image
Whitepaper

Clinical Evaluation for Medical Devices under MDR

This whitepaper will guide you through crucial regulatory documents pertaining to the clinical evaluation process of your medical device. Download now!
preview_image
Whitepaper

IVDR extension: what does this mean for you?

In this whitepaper, you will learn the impact of the IVDR transition extension and receive tips and strategies to navigate these regulatory changes.
preview_image
Whitepaper

State-of-the-art literature review: kick off the Clinical Evaluation of your Medical Device

This whitepaper will walk you through the steps of conducting solid systematic SOTA literature searches for your clinical evaluation. Download now.
preview_image
Whitepaper

Clinical investigations under MDR: key insights and practical experiences

This whitepaper covers clinical investigation authorization under MDR, the EU Legal Representative's role, and the MDR's impact on study conduct and post-market surveillance.
preview_image
Whitepaper

The pathway from idea to patient under MDR

This guide explains the pathway and steps needed to test your device in human subjects, aiming to get your product to market. Download now.
preview_image
Case study

CE Mark Renewal for bioXtra Products: A Success Story

Discover how Lifestream Pharma successfully renewed the CE mark for their BioXtra Dry Mouth products under the EU MDR. Learn about the challenges faced, the approach taken for compliance, and the results achieved.
preview_image
Webinar

Getting Started: Overcoming Initial Obstacles in Medical Device Software Development

Watch our webinar on demand and learn about regulatory obstacles, MDR, AI Act, and best practices for medical device software development and market entry.
preview_image
Webinar

Mastering Clinical Performance Studies under IVDR

In the evolving regulatory landscape of IVDs, demonstrating clinical performance is more crucial and challenging than ever. Discover more in this webinar on demand.
preview_image
Whitepaper

Clinical evidence for In Vitro Diagnostics under IVDR

In this whitepaper, we will guide you through the documents required for the demonstration of clinical evidence under the IVDR. Download now.
preview_image
Case study

Ensuring a smooth MDR transition for Oystershell's medical devices

The landscape of medical device regulations is constantly evolving, making it a challenge for companies to keep up. Our collaboration with Oystershell, which began in July 2023, highlights our expertise in transforming complex challenges into success stories, all with a touch of QbD Clinical magic.
preview_image
Case study

Successful clinical evaluation supports rapid CE marking of Minze Health's Uroflowmeter

QbD Clinical assisted Minze Health, a urology-focused medical devices company, in obtaining CE marking under MDR through clinical evaluation.